Biomedical, Clinical & Life Sciences

Request Ticket // Limit: 1 // Tickets Available: 1

Limiting Language 
An organization can submit only one application as the Lead Organization. Eligible organizations are welcome to collaborate with nonprofit organizations, companies, foundations, schools, colleges and universities, government agencies, individuals, and other entities (either U.S.-based or non-U.S.-based) to develop the solution. An organization can also serve as a partner on a team for multiple applications provided that each application proposes a separate, distinct solution

About the Challenge 
Building on its long-standing commitment to improve lives and communities, the Elevance Health Foundation recently launched a new initiative: Community Action Leadership. This initiative brings together external thought leaders from across a range of disciplines. Through their collective expertise and resources, the Foundation is addressing large-scale community health needs and incentivizing action for change. The inaugural Community Action Leadership challenge focuses on patient safety.

The Patient Safety Prize invites pioneering solutions in three key areas:

• Empowering Health Literacy for Safer Patient Care
• Innovating to Eliminate Medication Errors
• Promoting Fall-Free Futures

Apply to Internal Competition // Limit: 2 // Tickets Available: 2

Limiting Language
Two applications per institution (with a Unique Entity Identifier ) and a unique NIH eRA Institutional Profile File (IPF) number) are allowed per review round. The same or a similar topic may be submitted for subsequent review rounds involving the same or a similar team, but must be presented as a New application, not a Resubmission.

Program Description 
This Funding Opportunity Announcement (FOA) is designed to support highly integrated research teams of three to six Program Directors/Principal Investigators (PDs/PIs) to address ambitious and challenging research questions that are within the mission of NIGMS. Project goals should not be achievable with a collection of individual efforts or projects. Collaborative program teams are expected to accomplish goals that require considerable synergy and managed team interactions. Teams are encouraged to consider far-reaching objectives that will produce major advances in their fields.

This FOA is not intended for applications that are mainly focused on the creation, expansion, and/or maintenance of community resources, creation of new technologies, or infrastructure development.

Apply to Internal Competition // Limit: 2 // Tickets Available: 2

Limiting Language
No more than two applications are allowed per institution. If two applications are submitted, then the two awards must be for different target groups.

Additional detail from the Program Officer: The two target populations are up the applicant institution. If two applications targeting undergraduates are submitted, it is incumbent on the applicant institution to directly address how the two programs are distinct.

Purpose
 

Request Ticket // Limit: 1 // Tickets Available: 1

Limiting Language
An institution may submit only one application in response to this RFP.  

Background
The first heart transplant was performed in 1967, one of the most extraordinary feats of modern medicine. The system that supports it, however, has failed to evolve significantly since then, with none of the astonishing novel therapies we see being developed in other areas of medicine. Despite decades of innovation in almost all the other cardiovascular spheres, heart transplant care remains fragmented, inequitable, and frustratingly stagnant. Patients face ongoing cardiac rejection with imprecise methods to detect the immunologic process, potentially toxic immunosuppressive regimens which have not been updated substantially for two decades, and inconsistent outcomes—especially among Black recipients and pediatric populations. Data are siloed, research is underfunded, and quality improvement is virtually nonexistent. The majority of clinical practice guideline recommendations are driven by consensus rather than an evolving catalog of evidence. 

There is no unified national data infrastructure that can support retrospective and prospective research, no standardized quality improvement framework, and no coordinated research agenda to address these challenges. In short, we are crawling in one of the most high-stakes areas of healthcare. 

The American Heart Association is launching a bold, multi-phase initiative to transform heart transplantation care across the United States, a transformation in treatment built on three pillars: 

• A Global Heart Transplant Data Infrastructure In collaboration with key transplant organizations, the American Heart Association will manage a comprehensive heart transplant database, designed not as a static registry, but as a dynamic, harmonized data platform to drive research, quality improvement, and policy change.
• A Research Network for Breakthrough Science We are now recruiting from leading institutions to launch a research network focused on rejection detection, remote monitoring, viral load surveillance, and innovative, safer therapies. This network will be the sandbox for high-impact studies, including planning grants for clinical trials in immune tolerance, and chronic rejection.
• A Quality Improvement Infrastructure Modeled after our Get With The Guidelines® success, we will build a scalable Quality Improvement (QI) framework to standardize transplant care, reduce disparities, and improve long-term outcomes. This will drive system-wide change. 

Limit: 1 // Tickets Available: 0

Y. Shirai (Family and Community Medicine)

Limiting Language
An organization may only apply for this grant through one application per year and cannot apply for itself and be part of an application involving more than one organization.

Program Overview
Community Care Corps encourages organizations across the country to apply for 18-month grants ($30,000–$200,000) to develop and scale innovative volunteer programs that provide nonmedical assistance to older adults, adults age 18 and older with disabilities and family caregivers.

Projects funded through this initiative will increase the number of community-based volunteer programs available to provide nonmedical assistance while decreasing the number of older adults, adults with disabilities, and family caregivers who need assistance in maintaining independence in the community but are unable to obtain help. In doing so, the initiative will strengthen community-based supports that help people maintain independence, reduce unmet needs, and improve overall well-being.

Limit: 1 // Tickets Available: 0

A. Shamshiripour (Civil and Architectural Engineering and Mechanics) 

Limiting Language
You may submit only one application. If you submit more than one application, we will accept the last on-time submission.

Purpose
National Technical Assistance Programs (NTAPs) develop, deliver, coordinate, and evaluate technical assistance (TA) to existing and potential health centers, both directly and collaboratively with other HRSA-funded TA programs. FY 2026 NTAP award recipients will receive funding to provide high-impact TA that supports health centers to:

• Deliver comprehensive, high-quality primary health care.
• Improve chronic disease management, nutrition, and preventive services.
• Improve operational effectiveness, efficiency, and quality.
• Address emergent public health needs and priorities.
• Meet and exceed compliance with the Health Center Program and supplemental funding requirements.

Limit: 1 // Tickets Available: 0 

K. Huntoon (Neurosurgery) 

The University of Arizona Cancer Center (UACC) is coordinating this limited submission. For more information please contact: UACC-PreAward.

Limiting Language 
Each invited institution may submit one nomination: either a Translational or a V Scholar nominee.

Overview
Varied perspectives fuel innovation in cancer research. The objective of this Request for Applications (RFA) is to support exceptional, creative researchers who have navigated unique challenges to establish their careers. All scientists have personal journeys shaped by their unique experiences and perspectives, which bring valuable and potentially overlooked insights to cancer research. Applicants will be asked to describe how their unique experiences have influenced their career paths and research focus. 

No Applicants // Limit: 2 // Tickets Available: 2

Limiting Language 
Organizations may only submit a total of two applications during a community grant cycle and there cannot be any overlap in the budget items requested.

Program Overview
The Parkinson’s Foundation funds community grants that further the health, wellness and education of people with Parkinson's disease (PD) across the U.S.

The Foundation recognizes the unprecedented need for community-related programs and events. In the last three years the Foundation has awarded over $3 million in community grants to support programs providing services for people living with and affected by Parkinson's disease. These programs benefit communities in 39 states across the country.

Since 2011, the Foundation has invested more than $12.7 million in 969 community-based programs that improve life for people living with PD.

The 2026 Community Grant cycle will be supported by the estate of Stanley and Gloria Brams, members of the PD community from Brooklyn, New York.  Stanley was diagnosed at the age of 52. Following Stanley’s passing, his wife Gloria decided to dedicate a significant portion of their estate to the Foundation’s commitment to making an impact on local PD communities. In keeping with the Brams’ personal values, this generous donation will make a lasting impact for so many across the country.

Programs for the 2026 grant cycle should be geared towards expanding or creating access for populations of focus and must incorporate at least one of the following focus areas: 

1. Address mental health and PD
2. Reach and support care partners of individuals with PD
3. Educate and deliver exercise programs specifically designed for people with PD

Limit: 2 // Tickets Available: 0

M. Zhang (COM-P)
V. Kamath (COM-P)

Limiting Language
Each Nominating Institution may nominate up to two (2) applicants in Chemical Biology Research. 

Program Overview
Annually, the Ono Pharma Foundation considers proposals from PIs for research that could ultimately transform human health. Although additional areas of research may be added in future years, the Ono Pharma Foundation is only considering proposals for scientific research addressing Chemical Biology at this time.

Chemical Biology is defined as research that deals with the interface between chemistry and biology. The criteria for this field are deliberately broad so as not to disqualify potentially innovative and groundbreaking projects.

The goals of the Ono Initiative are to:

• Identify and develop innovative research proposals and results that could lead to the development of breakthrough treatment solutions for patients.
• Support academic research and the career development of promising young and established scientists.
• Build strong relationships within the community in order to lead to transformative research aligned with Ono Initiative's interest.

Eligibility:

• Applicants must meet the following requirements. LOIs and final Proposals from applicants not meeting the requirements listed below will not be considered.
  1. PIs applying must be working at one of the nominating institutions. Nominating institutions might be replaced or added to in subsequent years. For the list of nominating institutions, please see the FAQ.
  2. The PI must have an MD and/or a PhD degree.
  3. The PI must be a new applicant to the Ono Initiative, or, if they are a returning applicant, must be applying for a project different from the one they previously proposed.
  4. The PI must be a young and/or mid-career scientist (15 years or less of experience since starting an independent academic position).
  5. The PI must not have been, nor currently be, engaged in other sponsored research and/or collaborative research with Ono Pharmaceutical Co., Ltd. and/or grant program with Ono Pharma Foundation.
  6. The PI may not apply for funding to amplify current work. However, PIs may research a new idea based on a prior finding of the PI.
  7. The PI must not be a healthcare professional (defined as individuals currently holding an active state license for which they are (a) qualified to prescribe, administer, use or supply any medicinal or medical products or (b) perform any professional clinical services). A PI with an MD but without an active state medical license is still eligible.
  8. PIs serving on a healthcare formulary or similar committee are not eligible.

Limit: 4* (see below) // Tickets Available: 3

Cancer Data Science // Limit: 1 // Tickets Available: 1

Cancer Control Science // Limit: 1 // Tickets Available: 0
​J. Llavona-Ortiz (Cancer Center) 

Molecular Precision/Cancer Prevention // Limit: 1 // Tickets Available: 1 

Other Cancer Research // Limit: 1 // Tickets Available: 1

Number of Applications
Each eligible institution (defined as having a unique UEI number or NIH IPF number) may submit up to a combined total of four applications (one in Cancer Data Science, one in Cancer Control Science, one in Molecular/Precision Cancer Prevention, and one in Other Cancer Research) to any companion NOFO or any combination of companion NOFOs (PAR-23-286, PAR-23-287, and/or PAR-23-288).

Scientific Areas